Versant Capital Management’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.11K Buy
307
+287
+1,435% +$6.12K ﹤0.01% 2416
2026
Q2
$578 Buy
+20
New +$539 ﹤0.01% 2687

Other funds holding LEGN

Versant Capital Management's LEGN Position: Q3 2026 in Review

Versant Capital Management increased its Legend Biotech (LEGN) stake by 1,435% in Q3 2026, buying an estimated $6.12K and bringing the position to 307 shares worth $6.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.

Versant Capital Management first reported a position in LEGN in Q2 2026 and has held it in 2 quarters since. 197 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Versant Capital Management held 307 shares of Legend Biotech worth $6.11K as of Q3 2026.
  • Versant Capital Management bought 287 Legend Biotech shares in Q3 2026, an estimated $6.12K.
  • Legend Biotech made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2416 holding.
  • Versant Capital Management first reported a position in Legend Biotech in Q2 2026 and has held it in 2 quarters since.
  • 197 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.